E8X — elexxion AG Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €1.95m
- €5.96m
- €0.44m
Annual income statement for elexxion AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.648 | 0.679 | 0.732 | 1.03 | 0.444 |
Cost of Revenue | |||||
Gross Profit | 0.413 | 0.42 | 0.296 | 0.64 | 0.059 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.46 | 1.66 | 1.32 | 1.28 | 1.31 |
Operating Profit | -0.812 | -0.983 | -0.583 | -0.249 | -0.866 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.901 | -1.08 | -0.687 | -0.358 | -0.982 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.901 | -1.08 | -0.687 | -0.358 | -0.983 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.901 | -1.08 | -0.687 | -0.358 | -0.983 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.901 | -1.08 | -0.687 | -0.358 | -0.983 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.1 | -0.12 | -0.076 | -0.04 | -0.109 |
Dividends per Share |